Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

APLS

Apellis Pharmaceuticals, Inc.

Healthcare · USD

Set alert

Price alert · APLS

All alert types
41.03 USD 0.00 0.00%
As of May 15, 2026 Extended hours 41.06 +0.07%
Bid
41.04 × 14
Ask
41.05 × 1
41.03 Day range 41.05
16.83 52-week range 41.14
YTD
+63.34%
1 year
+150.79%
Open
41.05
Prev close
41.03
Mkt cap
5.25B
Vol
28.64M
Avg vol
7.54M
EPS
1.02
P/E
38.71
Div yield
0.00%
More statistics
Low
41.03
High
41.05
Beta
-0.25
Inst. own
110.43%
Dividend
0.00
Earnings
Jul 30, 2026

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for APLS has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

3.24 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E 140×
FY 2016: -9.4×FY 2017: -14.6×FY 2018: -5.6×FY 2019: -6.1×FY 2020: -12.5×FY 2021: -5.3×FY 2022: -8.4×FY 2023: -13.5×FY 2024: -19.9×FY 2025: 140×
FY 2016 5y median -8.4× FY 2025
P/S 3.2×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 17.2×FY 2021: 60.0×FY 2022: 72.8×FY 2023: 17.9×FY 2024: 5.1×FY 2025: 3.2×
FY 2016 5y median 17.9× FY 2025
P/B 8.6×
FY 2016: 10.7×FY 2017: 5.0×FY 2018: 4.5×FY 2019: 55.7×FY 2020: 21.0×FY 2021: 20.1×FY 2022: 32.3×FY 2023: 36.5×FY 2024: 17.3×FY 2025: 8.6×
FY 2016 5y median 20.1× FY 2025
P/FCF 70.3×
FY 2016: -9.8×FY 2017: -15.9×FY 2018: -5.5×FY 2019: -9.0×FY 2020: -25.9×FY 2021: -7.1×FY 2022: -10.6×FY 2023: -11.9×FY 2024: -44.8×FY 2025: 70.3×
FY 2016 5y median -10.6× FY 2025
EV/EBITDA 45.5×
FY 2016: 1455×FY 2017: -11.7×FY 2018: 194×FY 2019: -5.7×FY 2020: -13.2×FY 2021: -4.9×FY 2022: -8.2×FY 2023: -13.9×FY 2024: -26.0×FY 2025: 45.5×
FY 2016 5y median -8.2× FY 2025
EV/Sales 3.2×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 16.4×FY 2021: 53.5×FY 2022: 66.9×FY 2023: 17.3×FY 2024: 5.1×FY 2025: 3.2×
FY 2016 5y median 17.3× FY 2025
FCF Yield 1.4%
FY 2016: -10.2%FY 2017: -6.3%FY 2018: -18.3%FY 2019: -11.2%FY 2020: -3.9%FY 2021: -14.1%FY 2022: -9.4%FY 2023: -8.4%FY 2024: -2.2%FY 2025: 1.4%
FY 2016 5y median -8.4% FY 2025

Profitability

Gross Margin 89.8%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 90.0%FY 2021: 92.2%FY 2022: 92.5%FY 2023: 85.2%FY 2024: 84.9%FY 2025: 89.8%
FY 2016 5y median 89.8% FY 2025
Operating Margin 5.5%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -85.3%FY 2021: -805.7%FY 2022: -788.4%FY 2023: -130.4%FY 2024: -21.1%FY 2025: 5.5%
FY 2016 5y median -130.4% FY 2025
Net Margin 2.2%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -137.6%FY 2021: -1121.3%FY 2022: -864.7%FY 2023: -133.3%FY 2024: -25.3%FY 2025: 2.2%
FY 2016 5y median -133.3% FY 2025
ROE 6.0%
FY 2016: -114.0%FY 2017: -34.2%FY 2018: -79.2%FY 2019: -890.2%FY 2020: -168.6%FY 2021: -375.7%FY 2022: -383.9%FY 2023: -271.8%FY 2024: -86.6%FY 2025: 6.0%
FY 2016 5y median -271.8% FY 2025
ROIC 6.0%
FY 2016: -114.7%FY 2017: -28.9%FY 2018: -67.7%FY 2019: -88.3%FY 2020: -25.6%FY 2021: -71.1%FY 2022: -99.4%FY 2023: -94.4%FY 2024: -23.4%FY 2025: 6.0%
FY 2016 5y median -71.1% FY 2025
ROA 2.1%
FY 2016: -98.9%FY 2017: -28.0%FY 2018: -62.6%FY 2019: -78.3%FY 2020: -35.9%FY 2021: -84.6%FY 2022: -85.8%FY 2023: -67.0%FY 2024: -22.4%FY 2025: 2.1%
FY 2016 5y median -67.0% FY 2025

Growth (YoY)

Revenue 28.5%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -73.4%FY 2022: 13.3%FY 2023: 425.8%FY 2024: 97.0%FY 2025: 28.5%
FY 2016 FY 2025
Operating Income 133.6%
FY 2016: 41.4%FY 2017: -86.1%FY 2018: -152.0%FY 2019: -125.1%FY 2020: 25.8%FY 2021: -150.9%FY 2022: -10.9%FY 2023: 13.0%FY 2024: 68.1%FY 2025: 133.6%
FY 2016 FY 2025
EPS (diluted) 111.3%
FY 2016: 41.6%FY 2017: 0.7%FY 2018: -57.0%FY 2019: -112.8%FY 2020: 7.8%FY 2021: -92.6%FY 2022: 30.4%FY 2023: 27.6%FY 2024: 64.0%FY 2025: 111.3%
FY 2016 FY 2025
Free Cash Flow 151.0%
FY 2016: -37.9%FY 2017: -79.2%FY 2018: -181.7%FY 2019: -62.2%FY 2020: 22.0%FY 2021: -240.1%FY 2022: 8.7%FY 2023: -15.6%FY 2024: 85.2%FY 2025: 151.0%
FY 2016 FY 2025

Financial Health

Current Ratio 3.1×
FY 2016: 7.5×FY 2017: 27.8×FY 2018: 11.9×FY 2019: 5.7×FY 2020: 7.1×FY 2021: 6.3×FY 2022: 4.3×FY 2023: 3.1×FY 2024: 4.3×FY 2025: 3.1×
FY 2016 5y median 4.3× FY 2025
Quick Ratio 2.7×
FY 2016: 7.5×FY 2017: 27.8×FY 2018: 11.9×FY 2019: 5.7×FY 2020: 7.1×FY 2021: 6.1×FY 2022: 3.8×FY 2023: 2.5×FY 2024: 3.8×FY 2025: 2.7×
FY 2016 5y median 3.8× FY 2025
Debt / Equity 1.3×
FY 2016: 0.0×FY 2017: 0.2×FY 2018: 0.2×FY 2019: 4.6×FY 2020: 1.8×FY 2021: 1.1×FY 2022: 0.7×FY 2023: 0.6×FY 2024: 2.1×FY 2025: 1.3×
FY 2016 5y median 1.1× FY 2025
Net Debt / EBITDA 0.3×
FY 2016: -158×FY 2017: 2.9×FY 2018: -50.8×FY 2019: 0.7×FY 2020: 0.6×FY 2021: 0.6×FY 2022: 0.7×FY 2023: 0.5×FY 2024: -0.4×FY 2025: 0.3×
FY 2016 5y median 0.5× FY 2025
Interest Coverage 1.3×
FY 2016: 0.0×FY 2017: -524×FY 2018: -50.9×FY 2019: -54.5×FY 2020: -7.1×FY 2021: -40.5×FY 2022: -18.2×FY 2023: -17.5×FY 2024: -4.1×FY 2025: 1.3×
FY 2016 5y median -17.5× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31